A Named Patient Program (NPP), also known as a Managed Access Program, enables patients to access medicines
approved in other countries but not yet available locally. It is designed for patients with urgent medical
needs where no suitable treatment options exist in their home country.
Gain access to internationally approved medicines that are not yet available in your country. Through our
compliant Named Patient Program (NPP), we help patients and physicians source critical therapies safely,
legally, and efficiently.
We are a leading Indian company in the field of the Named Patient Program, helping patients and healthcare providers access life-saving therapies not yet available in the Indian market. Our mission is simple: compliant, reliable, and timely access to medicines that matter.
Your doctor evaluates your condition and prescribes the required treatment.
Submit your prescription and required medical documents online.
Our team processes your application for regulatory compliance.
Receive your medication with ongoing patient support.
A Named Patient Program (NPP), also known as a Managed Access Program, enables patients to access medicines approved in other countries but not yet available locally. It is designed for patients with urgent medical needs where no suitable treatment options exist in their home country.
We provide access to advanced cancer treatments including targeted therapies and immunotherapies. These therapies help improve outcomes and manage complex cancer conditions globally.
Access treatments for conditions such as anemia, leukemia, and clotting disorders, including advanced biologics and targeted medicines.
We support access to therapies for neurological conditions like multiple sclerosis, epilepsy, and rare genetic disorders.
Advanced therapies for autoimmune and inflammatory conditions such as rheumatoid arthritis and lupus.
Specialized treatments for kidney disorders including chronic kidney disease and renal complications.
Innovative therapies for IBD, Crohn’s disease, liver conditions, and digestive disorders.
Access global treatments for heart diseases including heart failure and cardiovascular disorders.
Specialized access to orphan drugs and treatments for rare and genetic conditions.
Support for complex and emerging conditions requiring innovative or highly specialized therapies.
In India, access to medicines under NPP requires prior approval from the Central Drugs Standard Control Organization (CDSCO). Once approved, medicines are imported through licensed distributors in compliance with all regulatory and safety standards.
Gain access to internationally approved medicines that are not yet available in your country. Through our compliant Named Patient Program (NPP), we help patients and physicians source critical therapies safely, legally, and efficiently.
Lorem ipsum dolor sit amet consectetur. Hendrerit suspendisse tristique nisl et. Sodales nisl.
Lorem ipsum dolor sit amet consectetur. Hendrerit suspendisse tristique nisl et. Sodales nisl.
Lorem ipsum dolor sit amet consectetur. Hendrerit suspendisse tristique nisl et. Sodales nisl.
Lorem ipsum dolor sit amet consectetur. Hendrerit suspendisse tristique nisl et. Sodales nisl.
Here are answer to questions we’re often asked.
Reach out, and let's create a universe of possibilities together!
We get back to you shortly during our working hours.
Trusted support you can rely on.
Mail Us At:
info@namedpatientprogram.com
Contact Us:
+91 9810469557